Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Russo

Showing results (271-280 of 357) with videos related to

Pageof 36
Sort By:
Clinical Genitourinary Cancer|June 26, 2022
Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell CarcinomaAndrew W Silagy, Amy L Tin, Phillip Rappold, et al.
World Journal of Urology|May 13, 2014
Impact of warm versus cold ischemia on renal function following partial nephrectomyScott E Eggener, Melanie A Clark, Sergey Shikanov, et al.
Clinical Genitourinary Cancer|July 22, 2019
Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution SeriesJozefina Casuscelli, Maria F Becerra, Kenneth Seier, et al.
Clinical Genitourinary Cancer|May 1, 2019
Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment OutcomesYasser Ged, Ying-Bei Chen, Andrea Knezevic, et al.
Proteomics|October 24, 2007
Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modificationsChenwei Liu, Nancy Shea, Sally Rucker, et al.
World Journal of Urology|August 24, 2014
Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systemsMassimiliano Spaliviero, Bing Ying Poon, Omer Aras, et al.
Urologic Oncology|September 16, 2019
Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinomaAndrew W Silagy, Jessica Flynn, Roy Mano, et al.
Urology Practice|January 28, 2025
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management OptionMark T Dawidek, Juan Sebastian Arroyave Villada, Katiana Vazquez-Rivera, et al.
European Urology|October 13, 2020
The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and ManagementStanley Weng, Renzo G DiNatale, Andrew Silagy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice GuidelineAntonio Finelli, Nofisat Ismaila, Bill Bro, et al.
Pageof 36

Showing results (271-280 of 357) with videos related to

Sort By:
Pageof 36
Clinical Genitourinary Cancer|June 26, 2022
Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell CarcinomaAndrew W Silagy, Amy L Tin, Phillip Rappold, et al.
World Journal of Urology|May 13, 2014
Impact of warm versus cold ischemia on renal function following partial nephrectomyScott E Eggener, Melanie A Clark, Sergey Shikanov, et al.
Clinical Genitourinary Cancer|July 22, 2019
Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution SeriesJozefina Casuscelli, Maria F Becerra, Kenneth Seier, et al.
Clinical Genitourinary Cancer|May 1, 2019
Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment OutcomesYasser Ged, Ying-Bei Chen, Andrea Knezevic, et al.
Proteomics|October 24, 2007
Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modificationsChenwei Liu, Nancy Shea, Sally Rucker, et al.
World Journal of Urology|August 24, 2014
Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systemsMassimiliano Spaliviero, Bing Ying Poon, Omer Aras, et al.
Urologic Oncology|September 16, 2019
Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinomaAndrew W Silagy, Jessica Flynn, Roy Mano, et al.
Urology Practice|January 28, 2025
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management OptionMark T Dawidek, Juan Sebastian Arroyave Villada, Katiana Vazquez-Rivera, et al.
European Urology|October 13, 2020
The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and ManagementStanley Weng, Renzo G DiNatale, Andrew Silagy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice GuidelineAntonio Finelli, Nofisat Ismaila, Bill Bro, et al.
Pageof 36